Sound View Wealth Advisors Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Sound View Wealth Advisors Group’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6,189	Closed	-$816K	–	435
2025 Q1	$816K	Sell	6,189 -59	-0.9%	-$7.35K	0.07%	203
2024 Q4	$522K	Sell	6,248 -9	-0.1%	-$740	0.04%	257
2024 Q3	$458K	Buy	6,257 +1,345	+27%	+$101K	0.04%	267
2024 Q2	$336K	Buy	+4,912	New	+$341K	0.03%	285

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Sound View Wealth Advisors Group's ITCI Position: Q2 2025 in Review

Sound View Wealth Advisors Group sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 6,189 shares — an estimated $816K sold.

Sound View Wealth Advisors Group first reported a position in ITCI in Q2 2024 and held it in 4 quarters. The position peaked at $816K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Sound View Wealth Advisors Group reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Sound View Wealth Advisors Group sold 6,189 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $816K.
Sound View Wealth Advisors Group first reported a position in Intra-Cellular Therapies Inc. in Q2 2024 and held it in 4 quarters.
Sound View Wealth Advisors Group's Intra-Cellular Therapies Inc. position peaked at $816K in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Sound View Wealth Advisors Group's 13F filing for Q2 2025, filed 7 Aug 2025.